Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 22–22 | Cite as

Afatinib

Development of resistance in adeno-squamous cell lung cancer: case report
Case report
  • 10 Downloads

Reference

  1. Kong M, et al. Osimertinib for Secondary T790M-Mutation-Positive Squamous Cell Carcinoma Transformation After Afatinib Failure. Journal of Thoracic Oncology 13: e252-e254, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.07.100 - South KoreaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations